Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients

Hsiang Ling Wang, Pei Ching Hsiao, Hsiu Ting Tsai, Chao Bin Yeh, Shun Fa Yang

研究成果: 雜誌貢獻文章

14 引文 (Scopus)

摘要

Plasma YKL-40 level has been reported as playing a significant role in community-acquired pneumonia (CAP). However, the correlation between plasma level of YKL-40 and the severity of CAP has not been reported. This study identifies the relationship between plasma level changes of the YKL-40 gene in adult patients hospitalized with CAP. The ELISA was used to measure the plasma YKL-40 level from 61 adult CAP patients before and after antibiotic treatment and from 60 healthy controls. The plasma YKL-40 levels were significantly increased in patients with CAP compared to normal controls. Moreover, the plasma concentration of YKL-40 correlated with the severity of CAP based on the pneumonia severity index (PSI) score (r = 0.630, p <0.001), the CURB-65 (confusion, uremia, respiratory rate, BP, age 65 years) score (r = 0.640, p <0.001), the Acute Physiology And Chronic Health Evaluation II (APACHE II) score (r = 0.539, p <0.001) and length of hospital stay (r = 0.321, p = 0.011), respectively. In conclusion, plasma YKL-40 may play a role in the diagnosis and clinical assessment of CAP severity, which could potentially guide the development of treatment strategies.

原文英語
頁(從 - 到)22817-22825
頁數9
期刊International Journal of Molecular Sciences
14
發行號11
DOIs
出版狀態已發佈 - 十一月 19 2013
對外發佈Yes

指紋

pneumonia
Pneumonia
Plasmas
Length of Stay
respiratory rate
Physiology
Antibiotics
APACHE
physiology
antibiotics
Uremia
confusion
Respiratory Rate
guy wires
genes
health
Genes
Health
Anti-Bacterial Agents
Enzyme-Linked Immunosorbent Assay

ASJC Scopus subject areas

  • Computer Science Applications
  • Molecular Biology
  • Catalysis
  • Inorganic Chemistry
  • Spectroscopy
  • Organic Chemistry
  • Physical and Theoretical Chemistry

引用此文

Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients. / Wang, Hsiang Ling; Hsiao, Pei Ching; Tsai, Hsiu Ting; Yeh, Chao Bin; Yang, Shun Fa.

於: International Journal of Molecular Sciences, 卷 14, 編號 11, 19.11.2013, p. 22817-22825.

研究成果: 雜誌貢獻文章

Wang, Hsiang Ling ; Hsiao, Pei Ching ; Tsai, Hsiu Ting ; Yeh, Chao Bin ; Yang, Shun Fa. / Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients. 於: International Journal of Molecular Sciences. 2013 ; 卷 14, 編號 11. 頁 22817-22825.
@article{6c0a5c72e8bf497eb5991f4dd67c7c9c,
title = "Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients",
abstract = "Plasma YKL-40 level has been reported as playing a significant role in community-acquired pneumonia (CAP). However, the correlation between plasma level of YKL-40 and the severity of CAP has not been reported. This study identifies the relationship between plasma level changes of the YKL-40 gene in adult patients hospitalized with CAP. The ELISA was used to measure the plasma YKL-40 level from 61 adult CAP patients before and after antibiotic treatment and from 60 healthy controls. The plasma YKL-40 levels were significantly increased in patients with CAP compared to normal controls. Moreover, the plasma concentration of YKL-40 correlated with the severity of CAP based on the pneumonia severity index (PSI) score (r = 0.630, p <0.001), the CURB-65 (confusion, uremia, respiratory rate, BP, age 65 years) score (r = 0.640, p <0.001), the Acute Physiology And Chronic Health Evaluation II (APACHE II) score (r = 0.539, p <0.001) and length of hospital stay (r = 0.321, p = 0.011), respectively. In conclusion, plasma YKL-40 may play a role in the diagnosis and clinical assessment of CAP severity, which could potentially guide the development of treatment strategies.",
keywords = "Community-acquired pneumonia, Severity, YKL-40",
author = "Wang, {Hsiang Ling} and Hsiao, {Pei Ching} and Tsai, {Hsiu Ting} and Yeh, {Chao Bin} and Yang, {Shun Fa}",
year = "2013",
month = "11",
day = "19",
doi = "10.3390/ijms141122817",
language = "English",
volume = "14",
pages = "22817--22825",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "11",

}

TY - JOUR

T1 - Usefulness of plasma YKL-40 in management of community-acquired pneumonia severity in patients

AU - Wang, Hsiang Ling

AU - Hsiao, Pei Ching

AU - Tsai, Hsiu Ting

AU - Yeh, Chao Bin

AU - Yang, Shun Fa

PY - 2013/11/19

Y1 - 2013/11/19

N2 - Plasma YKL-40 level has been reported as playing a significant role in community-acquired pneumonia (CAP). However, the correlation between plasma level of YKL-40 and the severity of CAP has not been reported. This study identifies the relationship between plasma level changes of the YKL-40 gene in adult patients hospitalized with CAP. The ELISA was used to measure the plasma YKL-40 level from 61 adult CAP patients before and after antibiotic treatment and from 60 healthy controls. The plasma YKL-40 levels were significantly increased in patients with CAP compared to normal controls. Moreover, the plasma concentration of YKL-40 correlated with the severity of CAP based on the pneumonia severity index (PSI) score (r = 0.630, p <0.001), the CURB-65 (confusion, uremia, respiratory rate, BP, age 65 years) score (r = 0.640, p <0.001), the Acute Physiology And Chronic Health Evaluation II (APACHE II) score (r = 0.539, p <0.001) and length of hospital stay (r = 0.321, p = 0.011), respectively. In conclusion, plasma YKL-40 may play a role in the diagnosis and clinical assessment of CAP severity, which could potentially guide the development of treatment strategies.

AB - Plasma YKL-40 level has been reported as playing a significant role in community-acquired pneumonia (CAP). However, the correlation between plasma level of YKL-40 and the severity of CAP has not been reported. This study identifies the relationship between plasma level changes of the YKL-40 gene in adult patients hospitalized with CAP. The ELISA was used to measure the plasma YKL-40 level from 61 adult CAP patients before and after antibiotic treatment and from 60 healthy controls. The plasma YKL-40 levels were significantly increased in patients with CAP compared to normal controls. Moreover, the plasma concentration of YKL-40 correlated with the severity of CAP based on the pneumonia severity index (PSI) score (r = 0.630, p <0.001), the CURB-65 (confusion, uremia, respiratory rate, BP, age 65 years) score (r = 0.640, p <0.001), the Acute Physiology And Chronic Health Evaluation II (APACHE II) score (r = 0.539, p <0.001) and length of hospital stay (r = 0.321, p = 0.011), respectively. In conclusion, plasma YKL-40 may play a role in the diagnosis and clinical assessment of CAP severity, which could potentially guide the development of treatment strategies.

KW - Community-acquired pneumonia

KW - Severity

KW - YKL-40

UR - http://www.scopus.com/inward/record.url?scp=84887933527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887933527&partnerID=8YFLogxK

U2 - 10.3390/ijms141122817

DO - 10.3390/ijms141122817

M3 - Article

C2 - 24256818

AN - SCOPUS:84887933527

VL - 14

SP - 22817

EP - 22825

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 11

ER -